Abstract
Importance While the COVID-19 pandemic disrupted regular hospital care and decreased overall volume of hospitalized patients, its impact on low-value care has not been investigated.
Objective To examine the impact of the COVID-19 pandemic on overuse rates.
Design A retrospective cohort study using Medicare fee-for-service claims.
Setting All outpatient and inpatient claims.
Participants Medicare beneficiaries aged 65 and over who met the criteria for one of 10 overuse measures were included, if they had a claim between January 1, 2019 to December 31, 2020.
Exposure Claims meeting overuse measure criteria over various time periods in 2020 were compared to the same period in the previous year: during the initial COVID-19 surge and shutdown (March 15 to May 2, 2020) and periods where states had high (if the mean 7-day case incidence was greater than 175 cases per 100,000 persons) or low COVID-19 incidence.
Main Outcomes and Measures The overuse measures in this study had two components: a denominator encompassing a particular patient cohort and a numerator to capture overuse of each service among patients within this cohort. We report claim volumes for both the denominator cohorts and overuse numerators as well as their rate differences (2020 versus 2019) using incidence rate ratios (IRRs) estimated using Poisson regressions.
Results There were 2,053,792 patients in 2019 and 1,699,807 in 2020 included across all 10 measure cohorts, with 2,112,904 (61.0%) female patients and a mean (SD) age of 76.5 (8.1) years. Across the 10 measures, 302,379 (14.7%) patients had a claim meeting the overuse criteria in 2019 and 234,481 (13.8%) in 2020. The COVID-19 shutdown had a large impact on overall cohort volume; there were 2,341,017 patients during this period, a decrease of 52.3% from 4,912,453 patients in the corresponding 2019 period. Both overuse volume and rates declined in 2020 compared to 2019. In April 2020, there were 3,955 overuse procedure claims (including spinal fusion/laminectomy, carotid endarterectomy, knee arthroscopy, hysterectomy and vertebroplasty) compared to 14,663 in 2019; an IRR of 0.64 (95% CI 0.62 to 0.67; p <0.001). After the COVID-19 shutdown period, 2020 overuse rates were mostly similar to rates in the corresponding 2019 period.
Conclusions and Relevance The COVID-19 shutdown period during March through May in 2020 had a drastic impact on both the overall volume of patients meeting one of 10 measure criteria and the rate of overuse for these patients. Overuse rates, however, returned to 2019 levels shortly after this shutdown period even as COVID incidence rose.
Competing Interest Statement
The authors have declared no competing interest.
Funding Statement
This project was self-funded by the Lown Institute.
Author Declarations
I confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.
Yes
The details of the IRB/oversight body that provided approval or exemption for the research described are given below:
The IRB of New England waived ethical approval for this work as there was no risk to patients and we did not report identifiable data. All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.
I confirm that all necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived, and that any patient/participant/sample identifiers included were not known to anyone (e.g., hospital staff, patients or participants themselves) outside the research group so cannot be used to identify individuals.
Yes
I understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).
Yes
I have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.
Yes
Data Availability
Medicare data was accessed after approvals and agreement with CMS. Individual hospital results will be available on https://lownhospitalsindex.org/. Other data can be accessed upon reasonable request to The Lown Institute, please contact info@lowninstitute.org.
